Expediting Patient-Oriented Research in Canada: Development of Myeloma Canada Research Network (MCRN)

Janet E Dancey

NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Multiple myeloma and immunoproliferative diseases

Monica M Bertagnolli

Alliance for Clinical Trials in Oncology Operations Center

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Robert L Comis

ECOG-ACRIN Operations Center

Multiple myeloma and immunoproliferative diseases

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Stephanie J Lee

Improving Outcomes Assessment in Chronic Graft versus Host Disease

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Charles D Blanke

SWOG Network Group Operations Center of the NCTN

Multiple myeloma and immunoproliferative diseases

Daniel M Sullivan

CRM1 INHIBITORS SENSITIZE MULTIPLE MYELOMA CELLS TO TOPOISOMERASE II AND PROTEASOME INHIBITORS

Multiple myeloma and immunoproliferative diseases

Ralph D Sanderson

Heparanase Regulation of Myeloma Metastasis: Mechanism and Therapy

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Charles Rabkin

BCL2 Translocations in Healthy Individuals

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies